BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33395044)

  • 1. Keratoacanthoma: Update on the Debate.
    Nirenberg A; Steinman H; Dixon A
    Am J Dermatopathol; 2021 Apr; 43(4):305-307. PubMed ID: 33395044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratoacanthoma and Keratoacanthoma-Like Squamous Cell Carcinoma: Similar Morphology but Different Pathogenesis.
    Watanabe IC; Magalhães RF; de Moraes AM; Stelini RF; Cintra GF; Metze K; Cintra ML
    Medicine (Baltimore); 2015 Jun; 94(23):e934. PubMed ID: 26061320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
    Cain CT; Niemann TH; Argenyi ZB
    Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the volume-weighted mean nuclear volume discriminates keratoacanthoma from squamous cell carcinoma.
    Binder M; Steiner A; Mossbacher U; Hunegnaw M; Pehamberger H; Wolff K
    Am J Dermatopathol; 1998 Oct; 20(5):453-8. PubMed ID: 9790104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glut-1 expression and in situ CD1a/CD57 immunologic deficit in keratoacanthoma and squamous cell carcinoma of immunocompetent patients.
    Cabibi D; Aragona F; Guarnotta C; Rodolico V; Zerilli M; Belmonte B; Schillaci L; Aragona F
    Appl Immunohistochem Mol Morphol; 2011 May; 19(3):239-45. PubMed ID: 21475039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization.
    Cheville JC; Bromley C; Argenyi ZB
    J Cutan Pathol; 1995 Dec; 22(6):546-50. PubMed ID: 8835173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant.
    Sánchez Yus E; Simón P; Requena L; Ambrojo P; de Eusebio E
    Am J Dermatopathol; 2000 Aug; 22(4):305-10. PubMed ID: 10949454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin.
    Krunic AL; Garrod DR; Madani S; Buchanan MD; Clark RE
    Br J Cancer; 1998 Apr; 77(8):1275-9. PubMed ID: 9579833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratoacanthoma (KA): An update and review.
    Kwiek B; Schwartz RA
    J Am Acad Dermatol; 2016 Jun; 74(6):1220-33. PubMed ID: 26853179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases.
    Cribier B; Asch P; Grosshans E
    Dermatology; 1999; 199(3):208-12. PubMed ID: 10592399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological diagnosis of epithelial crateriform tumors: Keratoacanthoma and other epithelial crateriform tumors.
    Ogita A; Ansai SI; Misago N; Anan T; Fukumoto T; Saeki H
    J Dermatol; 2016 Nov; 43(11):1321-1331. PubMed ID: 27076258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural course of keratoacanthoma and related lesions after partial biopsy: clinical analysis of 66 lesions.
    Takai T; Misago N; Murata Y
    J Dermatol; 2015 Apr; 42(4):353-62. PubMed ID: 25676096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratoacanthoma: a distinct entity?
    Gleich T; Chiticariu E; Huber M; Hohl D
    Exp Dermatol; 2016 Feb; 25(2):85-91. PubMed ID: 26476131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of S100 protein-positive cells in inflamed and non-inflamed keratoacanthoma and squamous cell carcinoma.
    Korenberg R; Penneys NS; Kowalczyk A; Nadji M
    J Cutan Pathol; 1988 Apr; 15(2):104-8. PubMed ID: 3372786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between keratoacanthoma and squamous cell carcinoma using TGF-alpha.
    Cabrijan L; Lipozencić J; Batinac T; Lenković M; Zgombić ZS
    Coll Antropol; 2013 Mar; 37(1):147-50. PubMed ID: 23697265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma].
    Corbalán-Vélez R; Martínez-Barba E; López-Poveda MJ; Vidal-Abarca Gutiérrez I; Ruíz-Maciá JA; Oviedo-Ramirez I; Martínez-Menchón T
    Actas Dermosifiliogr; 2012 May; 103(4):308-16. PubMed ID: 22176864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA image cytometry of keratoacanthoma and squamous cell carcinoma.
    Herzberg AJ; Kerns BJ; Pollack SV; Kinney RB
    J Invest Dermatol; 1991 Sep; 97(3):495-500. PubMed ID: 1875048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous Cell Carcinoma Arising From Keratoacanthoma: An Evaluation by RT-PCR.
    Ni C; Su A; Ra S; Li X; Cochran A; Binder S
    Am J Dermatopathol; 2016 Mar; 38(3):247-9. PubMed ID: 26067455
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
    Tan KB; Lee YS
    Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.